XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Grant revenue $ 5,650 $ 2,091 $ 14,893 $ 5,349
Collaboration revenue - related party 7,754 23,164 17,721 24,200
Collaboration revenue $ 65 $ 218 $ 319 $ 710
Type of Revenue [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember
Total revenues $ 13,469 $ 25,473 $ 32,933 $ 30,259
Operating expenses:        
Research and development 26,864 16,393 67,921 34,883
General and administrative 5,198 5,708 16,648 19,121
Impairment of assets 0 5,306 0 5,306
Total operating expenses 32,062 27,407 84,569 59,310
Loss from operations (18,593) (1,934) (51,636) (29,051)
Other income (expense):        
Interest income 1,182 950 3,707 2,894
Other income (expense), net (26) (10) (39) (17)
Total other income (expense), net 1,156 940 3,668 2,877
Net loss before income taxes (17,437) (994) (47,968) (26,174)
Income tax benefit (expense) 290 (2,211) 290 (2,211)
Net loss and comprehensive loss $ (17,147) $ (3,205) $ (47,678) $ (28,385)
Net loss per share attributable to common stockholders, basic $ (0.32) $ (0.06) $ (0.89) $ (0.54)
Net loss per share attributable to common stockholders, diluted $ (0.32) $ (0.06) $ (0.89) $ (0.54)
Weighted average common shares outstanding, basic 54,124,862 52,710,280 53,869,824 52,603,709
Weighted average common shares outstanding, diluted 54,124,862 52,710,280 53,869,824 52,603,709